Sanhoc Labs Limited - Due diligence report

A 360° intelligence report on Sanhoc Labs Limited: trust score, financial health, credit view, compliance, directors, growth and distress si…

2011-08-18 Hyderabad, Telangana Amalgamated Unlisted Active Compliant
Share
SL Sanhoc Labs Limited
Full Due-Diligence Report + Documents
  • Unlock all financial figures & 5-year trends
  • Full trust, health & credit-risk scores
  • Director details, charges & MCA documents
₹700 ₹449 Save ₹251 excl. GST
Or from ₹279/report with credits View credit packages
Company Credits – Starter
  • One credit unlocks this full due-diligence report
  • Use across any company’s report, anytime
  • Credits valid for 12 months
× ₹700 ₹279 = ₹2,790 60% off
Choose your own credit amount View credit packages

Sanhoc Labs Limited — 360° Intelligence Report

Generated from MCA filings & public records
56/100
Trust Score
Moderate

Sanhoc Labs Limited is assessed as Moderate with a Trust Score of 56/100. Sanhoc Labs Limited is a public limited indian non-government company incorporated in 2011, operating in the Chemicals and Materials sector. The company has shown revenue growth across its recent filed years. It reported a loss in its latest filed year. Based on MCA filings and public records, it currently shows a high compliance risk and high financial risk profile.

Report generated on 18 Jul 2026 from the latest processed filings. Sanhoc Labs Limited snapshot & full profile →

Financial Health › Weak
Overall Assessment CautionWeakNeutralGoodStrong Good
Compliance › Weak

Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.

02

Score Card

Higher is safer · rule-based & explainable
Trust ScoreModerate
56/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreCaution Indicated
43/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreCaution Indicated
40/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreModerate
50/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreLow Risk
90/100
Board strength, DIN status, churn and network.
Growth ScoreModerate
70/100
Revenue, profit, asset and hiring momentum.
Distress ScoreCaution Indicated
35/100
Early-warning signals - higher means fewer warnings.
03

Financial Intelligence Dashboard

Standalone · 5 filed year(s)

Unlock the full 5-year financial dashboard with charts and year-wise figures.

Get full access

Scores and observations on this page are already computed from the real filings - only the underlying figures are locked.

04

Credit & Compliance Intelligence

Why the scores are what they are
Credit Risk Score: 50/100 Moderate
  • Liabilities ≈ 38% EBITDA - stretched.
  • No open charges - unencumbered balance sheet.
  • Working-capital cover adequate.

Charges position: 0 open (-) · 0 satisfied (-).

Compliance Score: 43/100 Caution Indicated
  • Company status is "Amalgamated" - not Active.
  • Balance sheet slightly behind (Mar 2024).
  • 2 active GST registration(s).
05

Director Intelligence

Stability score: 90/100
NameDIN / PANDesignationAppointedTenureDIN status
SRINIVAS SISTLA 01234567 Director 01/04/2018 6 yrs Approved
PANIBHUSHAN REDDY BONGA 01234567 Director 01/04/2018 6 yrs Approved
VENKATA KRISHNA ANJANEYA PRASAD MARTHY 01234567 Director 01/04/2018 6 yrs Approved
  • 3 directors on the board.
  • No disqualified or deactivated DINs.
  • 1 director exit(s) in the last 3 years.
  • Average tenure above 5 years.
06

Ownership & Group Intelligence

As per FY 2020 annual return
Promoter holding
64.27%
Public / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
Axis Clinicals Limited
Subsidiaries
-
Group entities
-
Capital events
4 allotment(s) · 6 transfer(s)

Promoters hold a dominant controlling stake - exact percentages are part of the full report.

Group entityRelationship% held
Axis Clinicals Limited Holding Company 74.00%

Full shareholding pattern, group structure & capital events →

07

Risk Intelligence Center

Growth 70 · Distress 35
Growth signals & trust indicators
Revenue acceleration: +1.42 over 4 year(s).
Operating for 14+ years.
Active GST registration(s).
Distress signals & risk flags
Revenue declined year-on-year.
Losses deepening year-on-year.
Adverse company status: Amalgamated.
Compliance score is weak (43/100).
08

Stakeholder Verdicts

Vendor · Banker · Investor
Vendor due diligence44/100
Caution indicated
Suitability as a supplier / customer counterparty.
  • Check the compliance flags before onboarding.
  • 3 distress signal(s) - see Risk Center.
  • Financial filings available for verification.
Banker assessment45/100
Mixed indicators - deeper appraisal suggested
Indicative lending comfort for banks, NBFCs and trade credit.
  • Debt capacity assessed from filed statements.
  • No existing security registered - first-charge position available.
  • Compliance gaps should be priced into terms.
Investor view56/100
Mixed indicators
Growth quality and scalability through an investor lens.
  • 1 growth signal(s) detected.
  • Margin and return trends computable from filings.
  • Management team looks stable.
09

MCA Filings & Events Timeline

Latest 15 events
28 Sep 2024
Last AGM held
Annual general meeting
27 Sep 2024
Director ceased
PANIBHUSHAN REDDY BONGA
31 Mar 2024
Latest balance sheet
Filed with ROC
30 Dec 2023
Director appointed
PANIBHUSHAN REDDY BONGA (Director)
29 Sep 2018
Director ceased
SRINIVAS SISTLA
20 Aug 2018
Director ceased
VENKATA REDDY ARUMALLA
19 Jul 2018
Director appointed
SRINIVAS SISTLA (Director)
31 Mar 2017
Share transfer (FY 2017)
24650.00000000 shares to Suneela Rani
Share transfer (FY 2017)
49300.00000000 shares to and Penaka Suneela Rani Jointly
Share transfer (FY 2017)
100.00000000 shares to Sankara Reddy
Share transfer (FY 2017)
100.00000000 shares to Sanaka Reddy
30 Sep 2016
Director ceased
TAMILMANI SHANMUGAM
Director ceased
VENKATA KRISHNA ANJANEYA PRASAD MARTHY
02 May 2016
Director ceased
ASHISH KUMAR DASGUPTA
Director ceased
GELLI VENKATA SESHAIAH
10

Key Observations

Auto-generated from the data above
Revenue grew 2.1x over the last 4 financial year(s).
Net worth is positive.
3 active director(s) / partner(s); board looks stable and experienced.
2 active GST registration(s) indicate ongoing business operations.
EPFO-registered employer - verifiable payroll history exists.
Promoters hold a dominant controlling stake as per the FY 2020 annual return.
Capital has been raised through 4 security allotment(s) - amounts available in the full report.
11

Peers & Related Companies

Full peer comparison →
CompanyCINLocation
Tatanagar Hi Tech Casting Private Limited U24210JH1983PTC001820 Adityapur, Jharkhand, India
Adheswara Chemicals Private Limited U24294TN1987PTC013980 Chennai, Tamil Nadu, India
Vopec Pharmaceuticals U24231TN1996PTC035357 Chennai, Tamil Nadu, India
Srg Healthcare Private Limited U24232KA2003PTC032416 Davangere., Karnataka, India
Sigachi Laboratories Limited L24230TG1994PLC018786 Na, Telangana, India
Rumi Herbals P Ltd U24246TN1996PTC034562 Chennai, Tamil Nadu, India
Chemical Shoppe U51909GJ2016PTC093800 Ahmedabad, Gujarat, India
Ravindra Oxygen Company Private Limited U40200MH1995PTC091256 Nashik, Maharashtra, India
12

Who Uses This Report

CA · CS · Banker · Investor · Vendor
Chartered Accountants (CA)

Verify Sanhoc Labs Limited before audits and certifications: compliance score 43/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.

Company Secretaries (CS)

Track statutory health of Sanhoc Labs Limited: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.

Bankers & NBFCs

Current banker verdict: Mixed indicators - deeper appraisal suggested. Credit risk score 50/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.

Investors & Analysts

Investor view: Mixed indicators. Growth score 70/100, margin trends, ownership structure and peer set for Sanhoc Labs Limited - screening before a deeper diligence.

Vendors & Procurement Teams

Vendor verdict: Caution indicated. Trust score 56/100, distress signals and MSME payment-delay disclosures - know whether Sanhoc Labs Limited pays its suppliers before you extend credit terms.

Lawyers & Compliance Teams

Litigation footprint (no cases on record), regulatory flags, charge documents trail and director networks for Sanhoc Labs Limited - groundwork for KYC, onboarding and disputes.

13

Frequently Asked Questions

Is Sanhoc Labs Limited an active company?

Sanhoc Labs Limited has MCA status “Amalgamated” with a compliance score of 43/100 (Caution Indicated).

Is Sanhoc Labs Limited financially healthy?

Sanhoc Labs Limited has a Financial Health Score of 40/100 (Caution Indicated) based on its filed financial statements.

Should I do business with Sanhoc Labs Limited?

Its overall Trust Score is 56/100 (Moderate). Vendor verdict: Caution indicated. Review the risk flags in the Risk Intelligence Center before deciding.

Who controls Sanhoc Labs Limited?

The ultimate holding entity is Axis Clinicals Limited. 3 active director(s) are on record.

Does Sanhoc Labs Limited have loans or charges against its assets?

No charges are registered against this company - an unencumbered balance sheet.

Is Sanhoc Labs Limited up to date with its ROC filings?

Balance sheet slightly behind (Mar 2024). Overall compliance score: 43/100 (Caution Indicated).

Is it risky to lend to Sanhoc Labs Limited?

Its Credit Risk Score is 50/100 (Moderate). Banker verdict: Mixed indicators - deeper appraisal suggested.

Disclaimer: This report is generated automatically from MCA filings and public records as available in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice. Verify from official sources and consult a qualified professional before any business, lending or investment decision. If you represent this company and believe any information is inaccurate or outdated, report it here and we will review promptly.